CROWN is the first large, phase IIIb trial to evaluate the investigational use of LA Cabenuva versus daily oral therapy in ...
A retrospective study reported high recent use of GLP-1 receptor agonists in people living with HIV at a UK centre, with ...
As the population of people with HIV ages, researchers studied cognitive health changes; 46% of study participants were ...
University of British Columbia news release. The HPV vaccine provides strong, long-lasting protection for women living with ...
Among women with steatotic liver disease, HIV was associated with 48% greater adjusted odds of clinically significant ...
Women with HIV have almost twice the risk of CVD compared to women without HIV, while men with HIV have a 44% increased risk ...
Mirum Pharmaceuticals press release. Mirum Pharmaceuticals, Inc. announced the primary endpoint was met in the Phase 3 ...
ECDC released a report assessing the current situation regarding availability and access to prevention, testing, and ...
Researchers and clinicians are turning to new tools amidst an evolution in strategies for reducing cardiovascular risk in ...
WHO announced a major expansion of its prequalification programme to include a wider range of life-saving medical devices ...
A study showed that pooled sputum testing on Xpert MTB/RIF Ultra halves the required cartridges to make successful diagnoses ...
HIV-positive people had elevated rates of both infection-related malignancies and cancers not linked to infections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results